Moberg Derma reveals plan to list on NASDAQ OMX
This article was originally published in Scrip
Moberg Derma has dusted off its plans to float on the NASDAQ OMX in Stockholm, albeit with a lower price and fund raising target. The Swedish dermatology-focused pharma company has applied to raise SEK 74 million ($12.3 million) by issuing 2,551,724 shares at SEK 29 each. Last December, the company pulled its planned offering of 3.1 to 3.8 million shares at SEK 37 to SEK 45 each, citing insufficient demand to ensure a successful offering.